Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
DRUGNAME | PT | EventCount |
---|---|---|
Rituximab | Bone erosion | 2 |
RITUXIMAB | Brain oedema | 2 |
RITUXIMAB | Cardiomyopathy | 2 |
RITUXIMAB | Central nervous system lymphoma | 2 |
RITUXIMAB | Cerebral infarction | 2 |
RITUXIMAB | Chest pain | 2 |
RITUXIMAB | Cholecystitis infective | 2 |
RITUXIMAB | Cystitis haemorrhagic | 2 |
RITUXIMAB | Cytokine storm | 2 |
RITUXIMAB | Dermatitis | 2 |
Rituximab | Disseminated tuberculosis | 2 |
RITUXIMAB | Drug hypersensitivity | 2 |
Rituximab | Drug ineffective for unapproved indication | 2 |
RITUXIMAB | Dry skin | 2 |
Rituximab | Dysphagia | 2 |
Rituximab | Dyspnoea exertional | 2 |
Rituximab | Electrolyte imbalance | 2 |
RITUXIMAB | Encephalitis | 2 |
RITUXIMAB | Enterococcal infection | 2 |
RITUXIMAB | Enterocolitis infectious | 2 |
Total Records: 1,104 Number of Pages: 56